Resistance-Associated Substitutions (RAS) and Clinical Factors as Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients

Background: Direct acting antivirals (DAAs) have demonstrated remarkable efficacy, in achieving hepatitis C viral (HCV) elimination rates higher than 90%. One particular concern associated with treatment failure is the emergence of resistance associated substitutions (RASs) in the genome. The occurr...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Juferdy Kurniawan, Anugrah Dwi Handayu, Gita Aprilicia, Darlene Raudhatul Bahri, Irsan Hasan
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Interna Publishing 2024-10-01
Schriftenreihe:	Acta Medica Indonesiana
Schlagworte:	hepatitis c direct acting antiviral resistance associated substitutions mutation y93h region
Online-Zugang:	https://actamedindones.org/index.php/ijim/article/view/2625
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!